Total carbohydrates
Access and Affordability: Access and Affordability: Access and affordability challenges are a key factor preventing the GLP-1 market from reaching its peak potential, particularly in obesity where payer coverage is limited
Reflecting this evidence, major international guidelines, now provide class I recommendations for the use of SGLT2-I and GLP-1RA in patients with T2D and high cardiovascular risk,regardless of baseline glycemic control or HbA1c levels [7, 8]
The drugs may well be authentic, but they might also be expired, improperly stored, or contaminated
For someone who is already feeling disconnected from their body or struggling with how it looks, using a medication that reduces hunger cues can create a slippery slope to intentional restriction, guilt, and shame around eating